Physician profile
Keith Norris
NPI 1033245808
$13,879.69
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2021: $4,500 · 2022: $73.24 · 2023: $5,918 · 2024: $3,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,878 · Consulting Fee: $3,185 · Food and Beverage: $87.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,878.28 |
| Consulting Fee | $3,185.00 |
| Food and Beverage | $87.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $5,985.15 | 2019-2023 | Jardiance |
| Pfizer INC. | $4,500.00 | 2021 | |
| Astrazeneca Uk Limited | $3,185.00 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $73.24 | 2022 | |
| Opko Pharmaceuticals, LLC | $48.45 | 2024 | Rayaldee |
| Genentech, INC. | $39.28 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.66 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Norris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.